ABSTRACT
This chapter describes trade name, classification, approved indications for psychological disorders, available dosage forms, storage, and compatibility, usual dosage and administration, relative contraindications, and clinically significant drug interactions of Dezocine. Dezocine elicits its analgesic, CNS depressant, and respiratory depressant actions primarily by binding to the endorphin receptors in the CNS. Dezocine is addicting and habituating. Long-term dezocine pharmacotherapy, or regular personal use, may result in addiction and habituation. Dezocine pharmacotherapy commonly has been associated with nausea, sedation, and vomiting. Signs and symptoms of dezocine overdosage are similar to the signs and symptoms associated with other opiate analgesic overdosage. Dezocine overdosage requires emergency symptomatic medical support of body systems with attention to increasing dezocine elimination. The respiratory depressant action of dezocine may further compromise the respiratory function of these patients. The CNS depressant action of dezocine may adversely affect these mental and physical functions.
